Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)

Clinical trial NCT00629148 · COMPLETED

Trial details

NCT number: NCT00629148
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastasis, Neoplasm

Start date: 2007-08-01
Primary completion: 2009-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.